Co-Authors
This is a "connection" page, showing publications co-authored by DAVID HUI and DAVID SANGHYUN HONG.
Connection Strength
0.119
-
MABp1, a first-in-class true human antibody targeting interleukin-1a in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. Lancet Oncol. 2014 May; 15(6):656-66.
Score: 0.119
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.